
### [NCIT:C4016](http://purl.obolibrary.org/obo/NCIT_C4016)
**Label:** Malignant Bone Neoplasm

**Subclasses:** [NCIT:C136612](http://purl.obolibrary.org/obo/NCIT_C136612) (Bone Cancer by AJCC v8 Stage), [NCIT:C136613](http://purl.obolibrary.org/obo/NCIT_C136613) (Stage I Bone Cancer AJCC v8), [NCIT:C4834](http://purl.obolibrary.org/obo/NCIT_C4834) (Primary Bone Osteosarcoma), [NCIT:C115998](http://purl.obolibrary.org/obo/NCIT_C115998) (Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone), [NCIT:C4835](http://purl.obolibrary.org/obo/NCIT_C4835) (Ewing Sarcoma of Bone), [NCIT:C115997](http://purl.obolibrary.org/obo/NCIT_C115997) (Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone), [NCIT:C136610](http://purl.obolibrary.org/obo/NCIT_C136610) (Bone Cancer by AJCC v7 Stage), [NCIT:C6612](http://purl.obolibrary.org/obo/NCIT_C6612) (Stage III Osteosarcoma  AJCC v7), [NCIT:C3580](http://purl.obolibrary.org/obo/NCIT_C3580) (Metastatic Malignant Neoplasm in the Bone), [NCIT:C114782](http://purl.obolibrary.org/obo/NCIT_C114782) (Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone), [NCIT:C48876](http://purl.obolibrary.org/obo/NCIT_C48876) (Dedifferentiated Chordoma), [NCIT:C115351](http://purl.obolibrary.org/obo/NCIT_C115351) (Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone), [NCIT:C35871](http://purl.obolibrary.org/obo/NCIT_C35871) (Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone), [NCIT:C35870](http://purl.obolibrary.org/obo/NCIT_C35870) (Conventional Osteosarcoma), [NCIT:C53706](http://purl.obolibrary.org/obo/NCIT_C53706) (Radiation-Related Osteosarcoma), [NCIT:C53707](http://purl.obolibrary.org/obo/NCIT_C53707) (Bone Osteosarcoma), [NCIT:C53704](http://purl.obolibrary.org/obo/NCIT_C53704) (Secondary Osteosarcoma), [NCIT:C136616](http://purl.obolibrary.org/obo/NCIT_C136616) (Stage II Bone Cancer AJCC v8), [NCIT:C136619](http://purl.obolibrary.org/obo/NCIT_C136619) (Stage III Bone Cancer AJCC v8), [NCIT:C6705](http://purl.obolibrary.org/obo/NCIT_C6705) (Stage II Bone Sarcoma  AJCC v7), [NCIT:C6704](http://purl.obolibrary.org/obo/NCIT_C6704) (Stage I Bone Sarcoma  AJCC v7), [NCIT:C6902](http://purl.obolibrary.org/obo/NCIT_C6902) (Chondroid Chordoma), [NCIT:C8969](http://purl.obolibrary.org/obo/NCIT_C8969) (Parosteal Osteosarcoma), [NCIT:C6589](http://purl.obolibrary.org/obo/NCIT_C6589) (Childhood Parosteal Osteosarcoma), [NCIT:C6468](http://purl.obolibrary.org/obo/NCIT_C6468) (Stage III Bone Sarcoma  AJCC v7), [NCIT:C6622](http://purl.obolibrary.org/obo/NCIT_C6622) (Recurrent Bone Ewing Sarcoma), [NCIT:C6621](http://purl.obolibrary.org/obo/NCIT_C6621) (Metastatic Bone Ewing Sarcoma), [NCIT:C27482](http://purl.obolibrary.org/obo/NCIT_C27482) (Secondary Chondrosarcoma), [NCIT:C115368](http://purl.obolibrary.org/obo/NCIT_C115368) (Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone), [NCIT:C6701](http://purl.obolibrary.org/obo/NCIT_C6701) (Stage IV Osteosarcoma  AJCC v7), [NCIT:C6469](http://purl.obolibrary.org/obo/NCIT_C6469) (Osteosarcoma Arising in Paget Disease of Bone), [NCIT:C6623](http://purl.obolibrary.org/obo/NCIT_C6623) (Localized Bone Ewing Sarcoma), [NCIT:C114750](http://purl.obolibrary.org/obo/NCIT_C114750) (Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone), [NCIT:C6620](http://purl.obolibrary.org/obo/NCIT_C6620) (Primary Lymphoma of Bone), [NCIT:C5453](http://purl.obolibrary.org/obo/NCIT_C5453) (Skull Base Chordoma), [NCIT:C4881](http://purl.obolibrary.org/obo/NCIT_C4881) (Metastatic Malignant Neoplasm in the Spine), [NCIT:C7357](http://purl.obolibrary.org/obo/NCIT_C7357) (Periosteal Chondrosarcoma), [NCIT:C7598](http://purl.obolibrary.org/obo/NCIT_C7598) (Bone Liposarcoma), [NCIT:C36082](http://purl.obolibrary.org/obo/NCIT_C36082) (Metastatic Carcinoma in the Bone), [NCIT:C8563](http://purl.obolibrary.org/obo/NCIT_C8563) (Undifferentiated High Grade Pleomorphic Sarcoma of Bone), [NCIT:C7155](http://purl.obolibrary.org/obo/NCIT_C7155) (Primary Central Chondrosarcoma), [NCIT:C7154](http://purl.obolibrary.org/obo/NCIT_C7154) (Bone Leiomyosarcoma), [NCIT:C121881](http://purl.obolibrary.org/obo/NCIT_C121881) (Secondary Central Chondrosarcoma), [NCIT:C36074](http://purl.obolibrary.org/obo/NCIT_C36074) (Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone), [NCIT:C6590](http://purl.obolibrary.org/obo/NCIT_C6590) (Childhood Conventional Osteosarcoma), [NCIT:C87181](http://purl.obolibrary.org/obo/NCIT_C87181) (Stage II Bone Cancer  AJCC v7), [NCIT:C2947](http://purl.obolibrary.org/obo/NCIT_C2947) (Chordoma), [NCIT:C53958](http://purl.obolibrary.org/obo/NCIT_C53958) (High Grade Surface Osteosarcoma), [NCIT:C87185](http://purl.obolibrary.org/obo/NCIT_C87185) (Stage IV Bone Cancer  AJCC v7), [NCIT:C6706](http://purl.obolibrary.org/obo/NCIT_C6706) (Stage IV Bone Sarcoma  AJCC v7), [NCIT:C53953](http://purl.obolibrary.org/obo/NCIT_C53953) (Osteoblastic Osteosarcoma), [NCIT:C6709](http://purl.obolibrary.org/obo/NCIT_C6709) (Stage I Osteosarcoma  AJCC v7), [NCIT:C87184](http://purl.obolibrary.org/obo/NCIT_C87184) (Stage III Bone Cancer  AJCC v7), [NCIT:C27354](http://purl.obolibrary.org/obo/NCIT_C27354) (Recurrent Peripheral Primitive Neuroectodermal Tumor of Bone), [NCIT:C6479](http://purl.obolibrary.org/obo/NCIT_C6479) (Bone Angiosarcoma), [NCIT:C6710](http://purl.obolibrary.org/obo/NCIT_C6710) (Stage II Osteosarcoma  AJCC v7), [NCIT:C7644](http://purl.obolibrary.org/obo/NCIT_C7644) (Adamantinoma), [NCIT:C27353](http://purl.obolibrary.org/obo/NCIT_C27353) (Localized Peripheral Primitive Neuroectodermal Tumor of Bone), [NCIT:C136632](http://purl.obolibrary.org/obo/NCIT_C136632) (Bone Sarcoma by AJCC v7 Stage), [NCIT:C136633](http://purl.obolibrary.org/obo/NCIT_C136633) (Osteosarcoma by AJCC v7 Stage), [NCIT:C6475](http://purl.obolibrary.org/obo/NCIT_C6475) (Clear Cell Chondrosarcoma), [NCIT:C8776](http://purl.obolibrary.org/obo/NCIT_C8776) (Peripheral Primitive Neuroectodermal Tumor of Bone), [NCIT:C121933](http://purl.obolibrary.org/obo/NCIT_C121933) (Malignant Osteoclastic Giant Cell-Rich Tumor of Bone), [NCIT:C6476](http://purl.obolibrary.org/obo/NCIT_C6476) (Dedifferentiated Chondrosarcoma), [NCIT:C6470](http://purl.obolibrary.org/obo/NCIT_C6470) (Multifocal Osteosarcoma), [NCIT:C8970](http://purl.obolibrary.org/obo/NCIT_C8970) (Periosteal Osteosarcoma), [NCIT:C87178](http://purl.obolibrary.org/obo/NCIT_C87178) (Stage I Bone Cancer  AJCC v7), [NCIT:C121930](http://purl.obolibrary.org/obo/NCIT_C121930) (Primary Non-Hodgkin Lymphoma of Bone), [NCIT:C123398](http://purl.obolibrary.org/obo/NCIT_C123398) (Childhood Periosteal Osteosarcoma), [NCIT:C36303](http://purl.obolibrary.org/obo/NCIT_C36303) (Breast Carcinoma Metastatic in the Bone), [NCIT:C36308](http://purl.obolibrary.org/obo/NCIT_C36308) (Prostate Carcinoma Metastatic in the Bone), [NCIT:C36305](http://purl.obolibrary.org/obo/NCIT_C36305) (Lung Carcinoma Metastatic in the Bone), [NCIT:C6604](http://purl.obolibrary.org/obo/NCIT_C6604) (Bone Fibrosarcoma), [NCIT:C4304](http://purl.obolibrary.org/obo/NCIT_C4304) (Malignancy in Giant Cell Tumor of Bone), [NCIT:C136620](http://purl.obolibrary.org/obo/NCIT_C136620) (Stage IV Bone Cancer AJCC v8), [NCIT:C7812](http://purl.obolibrary.org/obo/NCIT_C7812) (Solitary Osseous Plasmacytoma), [NCIT:C4021](http://purl.obolibrary.org/obo/NCIT_C4021) (Chondroblastic Osteosarcoma), [NCIT:C53493](http://purl.obolibrary.org/obo/NCIT_C53493) (Mesenchymal Chondrosarcoma of Bone), [NCIT:C7134](http://purl.obolibrary.org/obo/NCIT_C7134) (Bone Surface (Peripheral) Osteosarcoma), [NCIT:C9312](http://purl.obolibrary.org/obo/NCIT_C9312) (Bone Sarcoma), [NCIT:C5156](http://purl.obolibrary.org/obo/NCIT_C5156) (Spinal Chordoma), [NCIT:C8461](http://purl.obolibrary.org/obo/NCIT_C8461) (Tibial Adamantinoma), [NCIT:C4020](http://purl.obolibrary.org/obo/NCIT_C4020) (Fibroblastic Osteosarcoma), [NCIT:C38157](http://purl.obolibrary.org/obo/NCIT_C38157) (Metachronous Osteosarcoma), [NCIT:C121941](http://purl.obolibrary.org/obo/NCIT_C121941) (Bone Epithelioid Hemangioendothelioma), 

**Class expressions from DL-Learner:**

- [NCIT:C36105](http://purl.obolibrary.org/obo/NCIT_C36105) (Indolent Clinical Course) 66.67%
- Thing 51.39%
- [NCIT:C35461](http://purl.obolibrary.org/obo/NCIT_C35461) (Clinical Course of Disease) 25.37%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 19.91%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 19.15%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 19.03%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 18.46%
- [UBERON:0010000](http://purl.obolibrary.org/obo/UBERON_0010000) (multicellular anatomical structure) 18.40%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 18.34%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 18.28%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 18.19%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 18.19%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 18.18%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 18.09%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 18.09%


